Última actualización:
March 8, 2023
IndieBio. Our business is to turn scientists into entrepreneurs who can save lives and save the planet (we call this “human and planetary health”). It was not that long ago (2014) that IndieBio exploded on the scene. We were the first VC to put a $2 million biotech lab in our office. We were the first accelerator to systematically write small checks into radical ideas using biology as a technology to disrupt markets outside healthcare. That portfolio of companies now has a cumulative enterprise value of nearly $4 billion — despite the average company being only 3 years old. Along the way our funds have expanded, as has our reach around the world.
US $
275,000
US $
525,000
Sin datos
Agnostic
Sin datos
Deseable, pero no obligatoria
National, LATAM, Asia, Africa, Europe, Oceania, North America (USA and Canada)
Beeflow, Caspr, NotCo, Michroma, Geltor, Perfect Day, Upside Foods, Mycoworks, The Every Company
Sí
No
4
